October 07, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for March 18, 2006 Subscribe to this News Feed  
 

Avage Skin Care is the Newest 3rd Generation Retinoid and is Commonly Sold by Plastic Surgeons

Download this press release as an Adobe PDF document.

Avage Skin Rejuvenation is very commonly prescribed thru dermatology and plastic surgery offices in the United States. Clinical studies have proven that AVAGE® Cream provides significant visible results when used as part of a total skin care and sunlight avoidance program.

(PRWEB) March 18, 2006 -- Avage Skin Care is the newest 3rd generation retinoid and is commonly sold by plastic surgeons.

Avage Skin Rejuvenation is very commonly prescribed thru dermatology and plastic surgery offices in the United States.

Avage® Cream is an elegant formulation that has been proven to effectively reduce facial fine wrinkles and certain types of dark and light spots on your face. Avage® Cream can reduce facial fine wrinkles - to make your skin noticeably smoother. Avage® is a new and effective agent in the fight against aging skin.

Avage® Cream contains the active ingredient tazarotene in an emollient cream formulation. Tazarotene is a retinoid, a potent prescription medication. Although scientists do not know how tazarotene works, they believe that it works below the skin’s surface to provide proven visible results. It is important that you use this medicine with a total skin care program and that you avoid exposure to sunlight. When used correctly, Avage® will improve certain signs of photoaging, including fine wrinkling and mottled hyper- and hypopigmentation. It also appears to improve skin evenness, minimize early precancerous lesions, decrease pore size and discoloration, including yellowing, bronzing, and brown spots. Collagen and ground substance production is increased, and keratinization is normalized, in effect "thickening" the living layers of skin, while "thinning" the dead outer layers of skin. Treatment with Avage® will not improve looseness or sagging of skin.

AVAGE® Cream is an elegant formulation that has been proven to effectively reduce facial fine wrinkles and certain types of dark and light spots on your face.

If you have facial wrinkles

AVAGE® Cream can reduce facial fine wrinkles—to make your skin noticeably smoother.

AVAGE® Cream contains the active ingredient tazarotene in an emollient cream formulation. Tazarotene is a retinoid, a potent prescription medication. Although scientists do not know how tazarotene works, they believe that it works below the skin’s surface to provide proven visible results.

If you have certain types of dark and light spots on your face
AVAGE® can diminish and fade these types of discoloration to give your skin a more even tone.

Clinical studies have proven that AVAGE® Cream provides significant visible results when used as part of a total skin care and sunlight avoidance program. It does not completely eliminate wrinkles. Nor does it repair sun-damaged skin, reverse skin aging from the sun, or bring back more youthful or younger skin.
Facial fine wrinkling

Certain types of facial decoloration

Avage can help transform your skin at the cellular level to look and act younger and healthier. Knowing more about the effects of the sun on your body may motivate you to protect your skin as you age. Skin health education is key.

Please visit us at www.prplastic.com, call us at 847.696.9900 for an Avage skin care consultation or Avage skin care product recommendations.

###

Trackback URL: http://www.prweb.com/pingpr.php/U2luZy1GYWx1LVN1bW0tTWFnbi1IYWxmLVplcm8=


See the original story at: http://www.prweb.com/releases/2006/03/prweb359633.htm
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
Sam Speron
Park Ridge Center for Plastic Surgery
847.696.9900
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2007, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright